Evidence map›Paper›PMID 31277226›Full record

ArticleJournal of clinical medicine2019

Genetic Testing to Predict Weight Loss and Diabetes Remission and Long-Term Sustainability after Bariatric Surgery: A Pilot Study.

Andreea Ciudin, Enzamaria Fidilio, Angel Ortiz, Sara Pich, Eduardo Salas, Jordi Mesa, Cristina Hernández, Olga Simó-Servat, Albert Lecube, Rafael Simó

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06226194 (Genetic Susceptibility to Predict Weight Loss After Bariatric Surgery), which is not on this map. Cited by 12 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 3 pooled it
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06226194 recruitingnot on this mapstarted 2024, after this paper: background citation

Genetic Susceptibility to Predict Weight Loss After Bariatric Surgery

Typeobservational_patient_registrySponsorInstitut de Recerca Biomèdica de LleidaRan2024 to 2028Enrolled6,966ConditionsBariatric Surgery Candidate, Obesity, Morbid, Genetic Predisposition, Metabolic Syndrome
3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 3 syntheses or guidelines pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Andreea CiudinInstitut de Recerca Vall d'Hebron, Universitat Autònoma de Barcelona (VHIR-UAB), 08035 Barcelona, Spain. aciudin@vhebron.net.
Enzamaria FidilioInstitut de Recerca Vall d'Hebron, Universitat Autònoma de Barcelona (VHIR-UAB), 08035 Barcelona, Spain.
Angel OrtizInstitut de Recerca Vall d'Hebron, Universitat Autònoma de Barcelona (VHIR-UAB), 08035 Barcelona, Spain.ORCID 0000-0002-2982-5896
Sara PichScientific Department, Gendiag.exe, Joan XXIII, 10, Esplugues de LLobregat, 08950 Barcelona, Spain.
Eduardo SalasScientific Department, Gendiag.exe, Joan XXIII, 10, Esplugues de LLobregat, 08950 Barcelona, Spain.
Jordi MesaInstitut de Recerca Vall d'Hebron, Universitat Autònoma de Barcelona (VHIR-UAB), 08035 Barcelona, Spain.
Cristina HernándezInstitut de Recerca Vall d'Hebron, Universitat Autònoma de Barcelona (VHIR-UAB), 08035 Barcelona, Spain.ORCID 0000-0002-3109-1721
Olga Simó-ServatInstitut de Recerca Vall d'Hebron, Universitat Autònoma de Barcelona (VHIR-UAB), 08035 Barcelona, Spain.
Albert LecubeCIBER de Diabetes y Enfermedades Metabólicas Asociadas, Instituto de Salud Carlos III, 08950 Barcelona, Spain.ORCID 0000-0001-9684-0183
Rafael SimóInstitut de Recerca Vall d'Hebron, Universitat Autònoma de Barcelona (VHIR-UAB), 08035 Barcelona, Spain. rafael.simo@vhir.org.ORCID 0000-0003-0475-3096
Universitat Autònoma de Barcelona · ESUniversitat de Lleida · ES

Funding

Instituto de Salud Carlos III PI 18/00964Instituto de Salud Carlos III Rio Hortega fellowshipPla Estrategic de Recerca i Innovació en Salut (PERIS 2016-2020) SLT002/16/00497
6 · The paper itself

Abstract

introductionThe aim of this pilot study was to assess genetic predisposition risk scores (GPS) in type 2 diabetic and non-diabetic patients in order to predict the better response to bariatric surgery (BS) in terms of either weight loss or diabetes remission. RESEARCH DESIGN AND

methodsA case-control study in which 96 females (47 with type 2 diabetes) underwent Roux-en-Y gastric by-pass were included. The DNA was extracted from saliva samples and SNPs were examined and grouped into 3 GPS. ROC curves were used to calculate sensitivity and specificity.

resultsA highly sensitive and specific predictive model of response to BS was obtained by combining the GPS in non-diabetic subjects. This combination was different in diabetic subjects and highly predictive of diabetes remission. Additionally, the model was able to predict the weight regain and type 2 diabetes relapse after 5 years' follow-up.

conclusionsGenetic testing is a simple, reliable and useful tool for implementing personalized medicine in type 2 diabetic patients requiring BS.

Indexed as

bariatric surgerydiabetesobesity

Identifiers

PMID31277226
PMCPMC6679039
OpenAlexW2954545914

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.